CAD 0.02
(50.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -0.46 EUR | 91.59% |
2022 | -561.07 Thousand EUR | 74.82% |
2021 | -2.22 Million EUR | -12.81% |
2020 | -1.97 Million EUR | -29.11% |
2019 | - CAD | -366.96% |
2018 | - CAD | -27.41% |
2017 | - CAD | -3.13% |
2016 | - CAD | -14.94% |
2015 | -216.93 Thousand CAD | -26.89% |
2014 | 275.75 Thousand CAD | 58.88% |
2013 | - CAD | 24.8% |
2012 | -552.87 Thousand CAD | 51.92% |
2011 | -1.14 Million CAD | 64.51% |
2010 | -3.24 Million CAD | -107.83% |
2009 | -1.55 Million CAD | -156.85% |
2008 | 1.31 Million CAD | -27.97% |
2007 | 3.8 Million CAD | -5.07% |
2006 | 4.01 Million CAD | 48.0% |
2005 | 2.71 Million CAD | -1.66% |
2004 | 2.75 Million CAD | 0.72% |
2003 | 2.73 Million CAD | 65.56% |
2002 | 1.65 Million CAD | 1163.5% |
2001 | -155.41 Thousand CAD | -112.41% |
2000 | 1.25 Million CAD | 128.21% |
1999 | 548.93 Thousand CAD | -17.45% |
1998 | 609.55 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 4153.00 EUR | -69.65% |
2024 Q1 | 11.79 Thousand EUR | 1455951.06% |
2023 Q3 | -45.56 Thousand EUR | 71.06% |
2023 Q1 | -35.82 Thousand EUR | -26.72% |
2023 Q2 | -157.44 Thousand EUR | -339.52% |
2023 FY | - EUR | 91.59% |
2023 Q4 | 64.54 Thousand EUR | 241.66% |
2022 Q2 | -518.48 Thousand EUR | -46.23% |
2022 Q4 | -28.26 Thousand EUR | -108.56% |
2022 FY | - EUR | 74.82% |
2022 Q3 | 330.06 Thousand EUR | 163.66% |
2022 Q1 | -354.57 Thousand EUR | 47.55% |
2021 Q1 | -488.68 Thousand EUR | 23.65% |
2021 Q4 | -676.03 Thousand EUR | -37.5% |
2021 Q2 | -572.67 Thousand EUR | -17.19% |
2021 Q3 | -491.65 Thousand EUR | 14.15% |
2021 FY | - EUR | -12.81% |
2020 Q1 | -414.39 Thousand CAD | -22550.93% |
2020 Q2 | -325.71 Thousand CAD | 21.4% |
2020 FY | - EUR | -29.11% |
2020 Q4 | -640.08 Thousand EUR | -8.74% |
2020 Q3 | -588.62 Thousand CAD | -80.72% |
2019 Q3 | -719.92 Thousand CAD | -36.36% |
2019 Q2 | -527.95 Thousand CAD | -107.0% |
2019 Q1 | -255.05 Thousand CAD | 41.2% |
2019 FY | - CAD | -366.96% |
2019 Q4 | -1829.50 CAD | 99.75% |
2018 Q2 | -40.39 Thousand CAD | 8.43% |
2018 Q1 | -44.11 Thousand CAD | 49.68% |
2018 FY | - CAD | -27.41% |
2018 Q3 | 12.9 Thousand CAD | 131.94% |
2018 Q4 | -433.76 Thousand CAD | -3461.97% |
2017 Q2 | -77.71 Thousand CAD | -24.64% |
2017 Q3 | -29.1 Thousand CAD | 62.54% |
2017 Q1 | -62.35 Thousand CAD | 53.42% |
2017 FY | - CAD | -3.13% |
2017 Q4 | -87.66 Thousand CAD | -201.17% |
2016 Q4 | -133.85 Thousand CAD | -219.15% |
2016 Q2 | -51.64 Thousand CAD | -53.88% |
2016 Q1 | -33.56 Thousand CAD | 78.25% |
2016 FY | - CAD | -14.94% |
2016 Q3 | -41.94 Thousand CAD | 18.8% |
2015 Q1 | -65.98 Thousand CAD | -321.23% |
2015 Q4 | -154.3 Thousand CAD | -305.1% |
2015 Q3 | -38.09 Thousand CAD | -199.08% |
2015 Q2 | 38.44 Thousand CAD | 158.26% |
2015 FY | - CAD | -26.89% |
2014 Q1 | -26.67 Thousand CAD | 78.07% |
2014 Q3 | -89.44 Thousand CAD | -146.96% |
2014 Q4 | -15.66 Thousand CAD | 82.49% |
2014 FY | - CAD | 58.88% |
2014 Q2 | -36.21 Thousand CAD | -35.78% |
2013 Q2 | -95.91 Thousand CAD | 7.58% |
2013 FY | - CAD | 24.8% |
2013 Q1 | -103.78 Thousand CAD | 23.28% |
2013 Q4 | -121.63 Thousand CAD | -207.24% |
2013 Q3 | 113.42 Thousand CAD | 218.26% |
2012 Q4 | -135.27 Thousand CAD | 35.3% |
2012 FY | - CAD | 51.92% |
2012 Q3 | -209.09 Thousand CAD | -101.3% |
2012 Q1 | -97.48 Thousand CAD | 87.68% |
2012 Q2 | -103.87 Thousand CAD | -6.55% |
2011 FY | - CAD | 64.51% |
2011 Q2 | -173.16 Thousand CAD | -161.83% |
2011 Q1 | 280.05 Thousand CAD | 116.74% |
2011 Q3 | -9.54 Million CAD | -5411.38% |
2011 Q4 | -791.39 Thousand CAD | 91.71% |
2010 Q1 | 865.1 Thousand CAD | 211.8% |
2010 Q2 | 1.47 Million CAD | 70.47% |
2010 FY | - CAD | -107.83% |
2010 Q4 | -1.67 Million CAD | -19.39% |
2010 Q3 | -1.4 Million CAD | -195.01% |
2009 Q3 | 185.79 Thousand CAD | 175.95% |
2009 Q4 | -773.77 Thousand CAD | -516.47% |
2009 Q2 | -244.62 Thousand CAD | 67.35% |
2009 FY | - CAD | -156.85% |
2009 Q1 | -749.14 Thousand CAD | 55.32% |
2008 Q1 | 1 Million CAD | 58.56% |
2008 Q2 | 620.15 Thousand CAD | -38.46% |
2008 Q4 | -1.67 Million CAD | -232.45% |
2008 Q3 | 1.26 Million CAD | 104.12% |
2008 FY | - CAD | -27.97% |
2007 Q4 | 635.51 Thousand CAD | 1.47% |
2007 Q2 | 1.11 Million CAD | -14.28% |
2007 Q1 | 1.3 Million CAD | 510.71% |
2007 FY | - CAD | -5.07% |
2007 Q3 | 626.32 Thousand CAD | -43.99% |
2006 Q2 | 1.33 Million CAD | 0.21% |
2006 FY | - CAD | 48.0% |
2006 Q3 | 1.12 Million CAD | -15.82% |
2006 Q1 | 1.33 Million CAD | 305.56% |
2006 Q4 | 213.58 Thousand CAD | -81.02% |
2005 Q2 | 1.05 Million CAD | 20.1% |
2005 FY | - CAD | -1.66% |
2005 Q4 | 328.91 Thousand CAD | 144.93% |
2005 Q1 | 874.55 Thousand CAD | 1076.73% |
2005 Q3 | -731.97 Thousand CAD | -169.69% |
2004 Q4 | 74.32 Thousand CAD | -88.74% |
2004 Q1 | 1.27 Million CAD | 339.26% |
2004 Q3 | 659.76 Thousand CAD | -29.08% |
2004 FY | - CAD | 0.72% |
2004 Q2 | 930.35 Thousand CAD | -27.13% |
2003 Q3 | 1.13 Million CAD | 28.05% |
2003 FY | - CAD | 65.56% |
2003 Q1 | 439.17 Thousand CAD | 41.37% |
2003 Q2 | 888.3 Thousand CAD | 64.96% |
2003 Q4 | 290.64 Thousand CAD | -74.45% |
2002 Q1 | 510.18 Thousand CAD | 183.01% |
2002 Q4 | 380.93 Thousand CAD | -7.42% |
2002 FY | - CAD | 1163.5% |
2002 Q3 | 411.44 Thousand CAD | -3.04% |
2002 Q2 | 424.36 Thousand CAD | -16.82% |
2001 Q2 | 237.07 Thousand CAD | 55.34% |
2001 Q1 | 152.61 Thousand CAD | 155.52% |
2001 FY | - CAD | -112.41% |
2001 Q4 | -614.58 Thousand CAD | -2662.47% |
2001 Q3 | 23.98 Thousand CAD | -89.88% |
2000 FY | - CAD | 128.21% |
2000 Q4 | -274.86 Thousand CAD | -244.32% |
2000 Q1 | 720.32 Thousand CAD | 919.04% |
2000 Q2 | 567.02 Thousand CAD | -21.28% |
2000 Q3 | 190.45 Thousand CAD | -66.41% |
1999 Q1 | 184.68 Thousand CAD | 0.0% |
1999 Q2 | 196.56 Thousand CAD | 6.43% |
1999 Q3 | 254.75 Thousand CAD | 29.6% |
1999 FY | - CAD | -17.45% |
1999 Q4 | -87.94 Thousand CAD | -134.52% |
1998 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 100.0% |
Ayurcann Holdings Corp. | -2.01 Million CAD | 100.0% |
Blueberries Medical Corp. | -1.22 Million CAD | 100.0% |
The BC Bud Corporation | -1.19 Million CAD | 100.0% |
BioNxt Solutions Inc. | -6.48 Million CAD | 100.0% |
CordovaCann Corp. | -1.6 Million CAD | 100.0% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | 100.0% |
Captor Capital Corp. | 2.42 Million CAD | 100.0% |
City View Green Holdings Inc. | -2.01 Million CAD | 100.0% |
1CM Inc. | 1.31 Million CAD | 100.0% |
Global Hemp Group Inc. | -24.79 Thousand CAD | 99.998% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 100.0% |
IM Cannabis Corp. | -2.79 Million CAD | 100.0% |
Lobe Sciences Ltd. | -4.4 Million CAD | 100.0% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | 100.0% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 100.0% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 100.0% |
Ovation Science Inc. | -778.83 Thousand CAD | 100.0% |
Pharmadrug Inc. | -1.33 Million CAD | 100.0% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 100.0% |
RAMM Pharma Corp. | -6.3 Million CAD | 100.0% |
RIV Capital Inc. | -20.28 Million CAD | 100.0% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 100.0% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 100.0% |
SLANG Worldwide Inc. | -2.95 Million CAD | 100.0% |
1933 Industries Inc. | -10.03 Million CAD | 100.0% |
Red Light Holland Corp. | -5.25 Million CAD | 100.0% |
Top Strike Resources Corp. | -767.99 Thousand CAD | 100.0% |
Xebra Brands Ltd. | -1.49 Million CAD | 100.0% |
Adastra Holdings Ltd. | -1.41 Million CAD | 100.0% |